Want to see CH:AEVS full AI Analyst Report?
AEVS Stock Chart & Stats
CHF13.55
-CHF0.15(-1.08%)
At close: 4:00 PM EST
CHF13.55
-CHF0.15(-1.08%)
Day’s Range― - ―
52-Week RangeCHF11.50 - CHF14.00
Previous CloseN/A
Volume1.36K
Average Volume (3M)11.01K
Market Cap
CHF1.10B
Enterprise ValueCHF1.99B
Total Cash (Recent Filing)CHF28.98M
Total Debt (Recent Filing)CHF949.83M
Price to Earnings (P/E)―
Beta-0.19
Next Earnings
Sep 17, 2026EPS Estimate
0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding85,151,470
10 Day Avg. Volume5,888
30 Day Avg. Volume11,014
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)2.21
Price to Sales (P/S)0.99
P/FCF Ratio230.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF17.00Price Target Upside25.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.16
Revenue Forecast (FY)CHF1.10B
Bulls Say, Bears Say
Bulls Say
Healthcare-focused Investment ModelA focused holding company model concentrated on hospitals, clinics and healthcare infrastructure creates durable cash and value-creation channels: operating income, dividends and eventual disposals. This specialization aligns with structural healthcare demand and enables operational oversight and synergies across assets.
Multi-year Revenue ExpansionSustained revenue growth over multiple years indicates expanding scale of clinical operations and market penetration. Durable top-line expansion provides a foundation for margin recovery and investment capacity, assuming management can improve cost control and translate scale into consistent profitability.
Consistently Positive Operating Cash FlowRising operating cash flow despite accounting losses signals a cash-generative core business, supporting working capital, capex and debt service. This durable cash generation reduces reliance on equity raises for operations and provides a pathway to delever if margins and free cash flow convert more sustainably.
Bears Say
Elevated LeverageDebt materially exceeding equity raises financial risk and constrains strategic flexibility. High leverage increases interest and refinancing exposure, limits ability to fund expansions or survive shocks, and forces management to prioritize deleveraging or asset sales over accretive investments.
Inconsistent And Recurring LossesRepeated net losses show growth hasn’t translated into durable earnings, preventing retained-earnings buildup needed to restore equity. Persistent unprofitability undermines credit metrics, increases reliance on external funding, and makes long-term compounding of shareholder value uncertain without structural cost or pricing fixes.
Volatile, Often Weak Free Cash FlowErratic free cash flow constrains the company’s ability to delever and reinvest even with positive operating cash flow. Ongoing capex or working-capital swings producing negative FCF raise the probability of asset disposals or external financing, limiting long-term stability and strategic optionality.
AEVIS VICTORIA SA News
AEVS FAQ
What was AEVIS VICTORIA SA’s price range in the past 12 months?
AEVIS VICTORIA SA lowest stock price was CHF11.50 and its highest was CHF14.00 in the past 12 months.
What is AEVIS VICTORIA SA’s market cap?
AEVIS VICTORIA SA’s market cap is CHF1.10B.
When is AEVIS VICTORIA SA’s upcoming earnings report date?
AEVIS VICTORIA SA’s upcoming earnings report date is Sep 17, 2026 which is in 39 days.
How were AEVIS VICTORIA SA’s earnings last quarter?
Currently, no data Available
Is AEVIS VICTORIA SA overvalued?
According to Wall Street analysts AEVIS VICTORIA SA’s price is currently Undervalued.
Does AEVIS VICTORIA SA pay dividends?
AEVIS VICTORIA SA pays a Quarterly dividend of CHF0.3 which represents an annual dividend yield of N/A. See more information on AEVIS VICTORIA SA dividends here
What is AEVIS VICTORIA SA’s EPS estimate?
AEVIS VICTORIA SA’s EPS estimate is 0.2.
How many shares outstanding does AEVIS VICTORIA SA have?
AEVIS VICTORIA SA has 85,151,470 shares outstanding.
What happened to AEVIS VICTORIA SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AEVIS VICTORIA SA?
Currently, no hedge funds are holding shares in CH:AEVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AEVIS VICTORIA SA
Aevis Victoria SA is a Swiss holding company with diversified interests spanning the healthcare, hospitality, lifestyle, and infrastructure sectors. Its operational structure is divided into key segments: Hospitals, Hospitality, Telemedicine, and Real Estate. The group manages an extensive portfolio, which includes 22 hospitals providing 1,496 beds, and oversees 941 rooms within its real estate holdings, representing a total rentable area of 188,109 square meters. Beyond its core hospital services, Aevis Victoria offers telemedicine, ambulance transport, and day clinic facilities. Its broad range of business ventures further encompasses patient hotels, "better aging" programs, radiology institutes, pharmacies, ophthalmology clinics, property management, stem cell applications, cosmetic services, and publishing, alongside organizing various seminars. The company's corporate headquarters are situated in Fribourg, Switzerland, and it operates as a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.
AEVS Stock 12 Month Forecast
Average Price Target
CHF17.00
▲(25.46% Upside)
Technical Analysis
Adecco Group AG
―
DKSH Holding AG
―
COMET Holding AG
―
Xlife Sciences Ltd.
―
SKAN Group AG
―